Dymista and Codeine drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Dymista (azelastine hydrochloride; fluticasone propionate) and Codeine (codeine sulfate). Common drug interactions include cushing's syndrome among females and klebsiella infection among males.
The phase IV clinical study analyzes what interactions people have when they take Dymista and Codeine. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.
What is Dymista?
Dymista has active ingredients of azelastine hydrochloride; fluticasone propionate. It is often used in allergies. eHealthMe is studying from 4,407 Dymista users. Check the latest studies of Dymista.
What is Codeine?
Codeine has active ingredients of codeine sulfate. It is often used in pain. eHealthMe is studying from 42,342 Codeine users. Check the latest studies of Codeine.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
28 people who take Dymista and Codeine together, and have interactions are studied.

What are the common drug interactions of Dymista and Codeine, by gender? *:
female:
- Cushing's syndrome (obesity, a rounded face, increased fat)
- Drug ineffective
- Left ventricular dysfunction
- Mean platelet volume decreased (less than normal average size of platelet cells in blood)
- Platelet count increased
- Seasonal allergy (allergic condition due to certain season)
- Fatigue (feeling of tiredness)
- Nausea (feeling of having an urge to vomit)
- Chronic kidney disease
- Cough
male:
- Klebsiella infection
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Chronic kidney disease
- Emotional distress
- Multiple injuries
- Depression
- Panic attack
- Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
What are the common drug interactions of Dymista and Codeine, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Blood immunoglobulin e increased
- Cushing's syndrome (obesity, a rounded face, increased fat)
- Mean platelet volume decreased (less than normal average size of platelet cells in blood)
- Platelet count increased
- Seasonal allergy (allergic condition due to certain season)
- Drug ineffective
- Chronic kidney disease
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
- Renal failure (kidney dysfunction)
50-59:
- Chronic kidney disease
- Left ventricular dysfunction
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Emotional distress
- Multiple injuries
- Depression
- Panic attack
- Drug hypersensitivity
- Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
60+:
- Klebsiella infection
- Fatigue (feeling of tiredness)
- Depressed mood
- Diarrhoea
- Drug ineffective
- Dyspnoea (difficult or laboured respiration)
- Eye disorder
- Haemoglobin decreased
- Headache (pain in head)
- Hepatotoxicity (chemical-driven liver damage)
What are the existing conditions these people have? *
- High Blood Pressure: 8 people, 28.57%
- Asthma: 6 people, 21.43%
- Primary Progressive Multiple Sclerosis (primary progressive inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 6 people, 21.43%
- Hyperkalemia (damage to or disease of the kidney): 4 people, 14.29%
- Bone Pain: 4 people, 14.29%
- Haemoglobin Decreased: 4 people, 14.29%
- Seasonal Allergy (allergic condition due to certain season): 4 people, 14.29%
- High Blood Cholesterol: 3 people, 10.71%
- Tumor Lysis Syndrome: 3 people, 10.71%
- Metastases To Bone (cancer spreads to bone): 3 people, 10.71%
* Approximation only. Some reports may have incomplete information.
Do you take Dymista and Codeine?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Dymista and Codeine:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Dymista:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Codeine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Dymista and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Codeine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on azelastine hydrochloride; fluticasone propionate and codeine sulfate (the active ingredients of Dymista and Codeine, respectively), and Dymista and Codeine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Levoxyl cause Dry Skin? - 5 seconds ago
- Could Cholestyramine cause Tinnitus? - 11 seconds ago
- Could Cotrim cause Exostosis? - 11 seconds ago
- Zyprexa vs. Belsomra, side effect and effectiveness comparison - 19 seconds ago
- Could Levetiracetam cause Thyroid Cancer? - 26 seconds ago
- Could Dilaudid cause Delirium? - 27 seconds ago
- Could Norco cause Fractured Sacrum? - 29 seconds ago
- Could Leflunomide cause Red Cell Distribution Width Increased? - 38 seconds ago
- Could Taxol cause Hypothyroidism? - 49 seconds ago
- Drug interactions of Rituxan and Vancomycin Hydrochloride - 49 seconds ago